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Abstract
Background: Research priority setting with stakeholders can help direct the limited resources for health research
toward priority areas of need. Ensuring transparency of the priority setting process can strengthen legitimacy and
credibility for influencing the research agenda. This study aims to develop a reporting guideline for priority setting
of health research.
Methods: We searched electronic databases and relevant websites for sources (frameworks, guidelines, or models
for conducting, appraising, reporting or evaluating health research priority setting, and reviews (including
systematic reviews)), and primary studies of research priority setting to July 2019. We inductively developed a list of
reporting items and piloted the preliminary guideline with a diverse range of 30 priority setting studies from the
records retrieved.
Results: From 21,556 records, we included 26 sources for the candidate REPRISE framework and 455 primary
research studies. The REporting guideline for PRIority SEtting of health research (REPRISE) has 31 reporting items
that cover 10 domains: context and scope, governance and team, framework for priority setting, stakeholders/
participants, identification and collection of priorities, prioritization of research topics, output, evaluation and
feedback, translation and implementation, and funding and conflict of interest. Each reporting item includes a
descriptor and examples.
Conclusions: The REPRISE guideline can facilitate comprehensive reporting of studies of research priority setting.
Improved transparency in research priority setting may strengthen the acceptability and implementation of the
research priorities identified, so that efforts and funding are invested in generating evidence that is of importance
to all stakeholders.
Trial registration: Not applicable.
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Background
Historically, the health research agenda has been largely
investigator-driven with limited input from other stake-
holders including patients, caregivers and the community
[1, 2]. Given the evident mismatch between the research
interests of patients and researchers, investment into
health research may be misdirected to areas of low priority
or fail to address important needs of relevant stakeholders
[1, 3–8]. For example, an analysis of 14 research priority
setting partnerships involving patients with different
medical conditions found that pharmacological interven-
tions were prioritized only in 18% of the total priorities
but 58% of the clinical trials in those fields evaluated
pharmacological interventions [4].
Globally, there have been calls for research priority
setting with stakeholders to be done at all levels of
health systems, jurisdictions, and health areas [9–12].
There is no consensus on the definition of research pri-
ority setting but most definitions refer to a range of
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activities that involve identifying, prioritizing, and
achieving consensus on the research areas or questions
of importance to stakeholders [13, 14]. The past two
decades have seen increasing efforts to develop better
ways to engage all relevant stakeholders, particularly pa-
tients, in setting priorities for research across different
health disciplines and populations [15–17]. Involving
stakeholders in an explicit manner in research priority
setting can help to: 1) ensure that funding decisions and
research meet critical evidence gaps to inform decision
making; 2) facilitate shared responsibility and account-
ability in implementing the research agenda; 3) improve
the relevance and legitimacy of research; and 4) ultim-
ately achieve better health outcomes [12, 17].
A diverse range of methods are used to prioritize
research given the different healthcare contexts, popula-
tions, environments and resources available in which the
priority setting is undertaken [14]. The process of
research priority setting can be complex, political and
value-laden. It can also be challenging to identify,
address and integrate the different perspectives and
values held by diverse stakeholders. While there is no
consensus on what constitutes “successful” research
priority setting, it has been advocated that processes
must be fair, legitimate, informed by credible evidence,
involve a broad spectrum of stakeholders, and be trans-
parent [12, 13, 18–20].
However, reviews of published research priority setting
exercises have consistently demonstrated a lack of trans-
parency because of suboptimal reporting [17, 21–26]. A
systematic review of research priority setting in child-
hood chronic disease, in which most studies were con-
ducted in the UK, US, and Australia, found that
methods for collecting and prioritizing research topics
were reported in only 50 (60%) of the 84 studies
included [23]. Another review of research priority setting
exercises in Zambia reported that details about the
process and the stakeholders involved were omitted in
the majority of studies [22], and similarly, a review of
studies in the Islamic Republic of Iran revealed that 22
(61%) of the 36 priority setting studies did not report
methods and only listed the research priorities [21].
Inadequate description of the stakeholders and the
methods makes it difficult to assess the validity of
research priorities identified, and limits the ability to
aggregate, analyze or compare research priorities that
have been established [27].
Frameworks and guidelines are available for conducting
and evaluating research priority setting, which mainly
focus on criteria related to the process rather than the
outcomes and impact of priority setting. There are no
published guidelines for reporting priority setting for
health research [5, 13, 18, 27–29]. Ensuring the transpar-
ency of the process for research priority setting can
strengthen legitimacy and credibility to support imple-
mentation and maximise impact. A reporting checklist for
research priority setting may facilitate more consistent
and comprehensive reporting and enable researchers and
end-users to better understand the processes taken in
developing research priorities. The aim of this paper is to
introduce the reporting guideline for priority setting of
health research (REPRISE), describe its development and
provide a rationale for the items included.
Methods
REPRISE development
We used the Enhancing the Quality and Transparency of
Health Research (EQUATOR) toolkit [30], for developing
the REPRISE Guideline and reported our approach based
on the “Guidance for developers of health research report-
ing guidelines” where possible [31]. We have also
registered REPRISE with the EQUATOR Network.
Purpose and context
The purpose of REPRISE is to facilitate comprehensive
and transparent reporting of health research priority
setting exercises, in which there is direct involvement of
stakeholders setting research priorities. The REPRISE
guideline is flexible so that it may be used for a range of
approaches. The scope of REPRISE does not cover
approaches without direct involvement of stakeholders
such as documentary analysis (e.g. evidence mapping),
and econometrics methods (e.g. value of information).
REPRISE is not intended for use to appraise the quality
of priority setting studies, establish or evaluate criteria
for research priorities (e.g. evidence gaps, prevalence of
disease, economic considerations), and does not recom-
mend a preferred approach.
Identify the need for a guideline
Systematic reviews have consistently shown the reporting
of the process of research priority setting with stake-
holders is highly variable and limited with many details
omitted [21, 23, 25, 26, 32]. The need for a reporting
guideline has also been identified through our workshops
and forums at national and international meetings (e.g.
Cochrane Colloquia and Symposia [12, 33–35]; James
Lind Alliance [5]), and through our collective experiences
of conducting, publishing, reviewing, and using research
priority setting studies.
We conducted a comprehensive search for frame-
works, guidelines or models for conducting, appraising,
reporting and evaluating health research priority setting,
reviews (including systematic reviews) of research prior-
ity setting studies, and primary research priority setting
studies. We searched electronic databases including
MEDLINE, Embase, CINAHL, PsycINFO from inception
to 23rd July 2019 using sensitive search strategies
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provided in Additional file 1. We used Medical Subject
Heading (MeSH) terms and text words for research
priorities and combined this with terms related to
reporting, conduct and evaluation. We also searched
Google Scholar, relevant organizational websites (e.g.
WHO, EQUATOR, Cochrane, James Lind Alliance and
PCORI), and reference lists of articles. The search results
are shown in Additional file 2. From the 21,556 records
retrieved, we identified 13 frameworks or guidelines for
conducting or evaluating research priority guidelines [5, 13,
18–20, 28, 36–42] (none designed for reporting research
priority setting), and 13 reviews of research priority setting
[15–17, 21–27, 32, 43, 44], of which four were systematic
reviews [23–26]. (Additional file 3) We also identified 455
primary research priority setting studies.
Generating reporting items for the candidate checklist
We extracted items related to the process of priority-
setting from the frameworks and systematic reviews
included (the sources are listed in Additional file 2).
We translated these into reporting items for the can-
didate REPRISE reporting guidelines by grouping
similar items and rephrasing the statements as a
reporting item. We inductively developed the initial
list of reporting items. This was reviewed by two
other investigators (AB, AM) to ensure all relevant
items were included in the list. The reporting items
were compiled into 10 domains: context and scope,
governance and team, framework for priority setting,
stakeholders/participants, identification and collection
of priorities, prioritization of research topics, output,
evaluation and feedback, translation and implementa-
tion, and funding and conflict of interest. (Add-
itional file 4) We imported all sources (frameworks
and systematic reviews) into HyperRESEARCH soft-
ware for coding textual data, and AT conducted line-
by-line coding of each source to the initial items. We
generated a report of each reporting item and the
corresponding coded text (content). We developed de-
scriptors and examples based on the content of the
sources and input from all the investigators. The
sources that contributed to each reporting item, and
examples of the original extracted items are shown in
Additional file 5.
Pilot testing the checklist
The preliminary REPRISE guideline was presented at the
Australasian Cochrane Symposium, in which partici-
pants used the guideline to assess the reporting of a
research priority exercise, and provided feedback on the
guideline [34]. We subsequently used the REPRISE
guideline in two systematic reviews of research priority
setting studies in childhood chronic conditions [23] and
organ transplantation [26]. We also applied the
preliminary guideline to report a research priority setting
exercise in health communication and participation [45].
In the final stage, we piloted the guideline with research
priority setting studies. We used a purposive sampling
strategy to select 30 priority setting exercises from the total
of 455 studies retrieved from the search to ensure a diverse
range of health topics, regions, stakeholders involved,
framework or methods used, and type of output. Using a
standardized data extraction template with the reporting
items from the REPRISE guideline, the investigators (two
per study) independently assessed if the study reported on
each item (yes/no), added comments, and suggested new
reporting items that were not yet captured. The results are
provided in Additional file 6. After completion, the investi-
gators discussed the relevance and applicability of the
items, clarity of the items, comprehensiveness of the
descriptor and examples, and any new reporting items
proposed. These were integrated into the final reporting
guideline, which was reviewed and approved by all
investigators.
REPRISE framework: content and rationale
The REPRISE guideline includes ten domains and a total
of 31 reporting items with a descriptor and examples pro-
vided. (Table 1) The principles, rationale, and explanation
for the domains are detailed below, which are based on
the synthesis of sources listed in Additional file 3, priority
setting studies, and discussion among the investigators.
Context and scope (items 1–7)
Establishing the context and scope is recommended
as these “underpin the process of research priority
setting,” [13] including the selection of relevant stake-
holders and methods used. In terms of geographical
scope, priority setting may be done at an institutional,
local, national, or international level [13, 19, 21, 39–
41]; recognizing that each will have its own “sense of
mandate, capacity, culture, and resources.” [39] Re-
search priorities may address a specific condition, dis-
ease or risk factor (e.g. cancer, mental health),
population (e.g. elderly, adolescents), health system, re-
search design, or interventions (e.g. vaccination) [5, 13, 19,
21, 24, 27, 37, 38, 40, 41, 44]. These can be decided upon
based on the evidence [5, 38] and initial deliberations with
stakeholders [38].
The intended beneficiaries [13] may include patients,
caregivers, or the general community who could benefit
from the priority setting exercise, and the target audience
are those who have the potential to implement or fund the
research priorities identified [13, 17, 39–41]. The focus,
content and type of research to be considered can deter-
mine the scope of the priority setting exercise. In terms of
the broad research areas, these generally span public health,
health services, clinical research and basic science [24, 37,
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Table 1 Reporting guideline for health research priority setting with stakeholders (REPRISE)
No Item Descriptor and/or examples
A Context and scope
1 Define geographical scope Global, regional, national, city, local area, institutional/organizational
level, health service
2 Define health area, field, focus Disease or condition specific, interventions, healthcare delivery,
health system
3 Define the intended beneficiaries This may include the general population or a specific population
based on demographic (age, gender), clinical (disease, condition),
or other characteristics who may benefit from the research
4 Define the target audience of the priorities Policy makers, funders, researchers, industry or others who have the
potential to implement the priorities identified
5 Identify the research area Public health, health services research, clinical research, basic science
6 Identify the type of research questions Etiology, diagnosis, prevention, treatment (interventions), prognosis,
health services, psychosocial, behavioral and social science, economic
evaluation, implementation; this may not be pre-defined
7 Define the time frame Interim, short-term, long-term priorities, plans to revise and update
B Governance and team
8 Describe the selection and structure of the leadership and
management team
Those responsible for initiating, developing, and guiding the process
for priority setting, and examples of structures include; Steering
Committee, Advisory Group, Technical Experts
9 Describe the characteristics of the team Stakeholder group or role, institutional affiliations, country or region,
demographics (e.g. age sex), discipline, experience, expertise
10 Describe any training or experience relevant to conducting
priority setting
Consultants or advisors, members with experience or skills relevant to
the conducting priority-setting e.g. qualitative methods, surveys,
facilitation
C Framework for priority setting
11 State the framework used (if any) James Lind Alliance, COHRED, CHNRI, Dialogue Model, no framework
(general research priority setting)
D Stakeholders or participants
12 Define the inclusion criteria for stakeholders involved in
priority-setting
Patients, caregivers, general community, health professionals,
researchers, policy makers, non-governmental organizations,
government, industry; specific groups including vulnerable and
marginalized populations
13 State the strategy or method for identifying and engaging
stakeholders
Partnership with organizations, social media, recruitment through
hospitals
14 Indicate the number of participants and/or organizations
involved
Number of individuals and organizations, include number by
stakeholder group
15 Describe the characteristics of stakeholders Stakeholder group, demographic characteristics, areas of interest and
expertise, discipline, affiliations
16 State if reimbursement for participation was provided Cash, vouchers, certificates, acknowledgement; what purpose e.g.
travel, accommodation, honorarium
E Identification and collection of research priorities
17 Describe methods for collecting initial priorities Methods e.g. Delphi survey, surveys, nominal group technique,
interviews, focus groups, meetings, workshops; prioritization e.g.
voting, ranking; mode e.g. face-to-face, online; may be informed
by evidence e.g. systematic reviews, reviews of guidelines/other
documents, health technology assessment
18 Describe methods for collating and categorizing priorities Taxonomy or other framework used to organize, summarise, and
aggregate topics or questions
19 Describe methods and reasons for modifying (removing,
adding, reframing) priorities
Based on scope, clarity, definition, duplication, other criteria
20 Describe methods for refining or translating priorities into
research topics or questions
Reviewed by Steering Committee or project team
21 Describe methods for checking whether research questions
or topics have been answered
Systematic reviews, evidence mapping, consultation with experts
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41, 44]. The types of research questions that may be in-
cluded can range from etiology, diagnosis, prognosis, treat-
ment, to behavioural; and social science, economic
evaluation and implementation [23, 24, 27, 39]. It is not ne-
cessary for the type of research questions to be determined
a priori.
Providing an estimated time frame that the priorities are
expected to be valid or relevant may be relevant. This is
because research priorities may evolve due to the develop-
ment of new technology or interventions, emerging evi-
dence, or changes to the health system or socio-political
contexts [13, 17, 19, 37–39, 41, 42]. If there are plans to
update the priority setting or to monitor the priorities for
the need to update, these could be described. There has
been suggestion of 3–5 year cycles of prioritization if the
priority setting exercise is to be repeated [37, 38].
Governance and team (items 8–10)
It has been argued that priority setting requires “cred-
ible” [39] leadership to support acceptability and up-
take. This may require leaders who are trusted by
stakeholders and who have the necessary expertise,
knowledge, decision-making skills, and ability and
deliver the project. The leadership and management
team is usually responsible for overseeing, developing and
implementing the process for priority setting [5, 13, 19].
The leadership group may take the form of, for example,
an Executive Committee, Advisory Group, Technical Ex-
pert Group [13]. Members of the leadership team would
generally be expected to contribute broad and relevant
collective insights, harness their networks for engagement
and partnership; and include a diversity of members to
offer legitimacy to wider stakeholder networks (e.g. pa-
tients, caregivers, researchers, policy makers, clinicians,
representatives from other non-government or govern-
ment organizations) [5, 21], and those with technical ex-
pertise [5]. The membership and selection of stakeholders
may need to take into consideration the need for equity
[12, 36]. Also, it has been suggested that the involvement of
individuals or organizations with experience in priority set-
ting and relevant research skills can ensure a “high quality
process.” [5, 13, 40] With regard to facilitators, neutrality
and facilitations skills may be important to elicit input from
diverse and mixed stakeholders [5, 36].
Table 1 Reporting guideline for health research priority setting with stakeholders (REPRISE) (Continued)
No Item Descriptor and/or examples
22 Describe number of research questions or topics Number of priorities at each stage of the process
F Prioritization of research topics/questions
23 Describe methods and criteria for prioritizing research topics
or questions
Methods e.g. Delphi survey, surveys, nominal group technique,
interviews, focus groups, meetings, workshops;
Prioritization e.g. voting, ranking;
Mode e.g. face-to-face, online;
Criteria e.g. need, feasibility, novelty, equity
24 State the method or threshold for excluding research topics/
questions
Thresholds for ranking scores, proportions, votes; other criteria
G Output
25 State the approach to formulating the research priorities Area, topic, questions, PICO (population, intervention, comparator,
outcome)
H Evaluation and feedback
26 Describe how the process of prioritization was evaluated Survey, workshop
27 Describe how priorities were fed back to stakeholders and/or
to the public; and how feedback (if received) was addressed
and integrated
Public meetings or workshop, newsletters, website, email, online
presentations
I Implementation
28 Outline the strategy or action plans for implementing priorities Communication with target audience, via policies and funding
29 Describe plans, strategies, or suggestions to evaluate impact Integration in decision-making, funding allocation, review of relevant
documents
J Funding and conflict of interest
30 State sources of funding Name sources of funding for the priority-setting exercise; if relevant
include the budget and/or cost
31 Declare any conflicts or competing interests State any conflicts of interest that may be at an individual level and/or
at a contextual level (e.g. political issues, controversies) that may affect
the process, output or implementation.
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Framework for priority setting (item 11)
Some priority setting studies use or adapt frameworks to
guide the process [17, 22, 23, 25, 44]. Common frame-
works include the James Lind Alliance [5], Council on
Health Research for Development Essential National
Health Research (COHRED/ENHR) [19], Essential Na-
tional Health Research (EHNR), Child Health and Nutri-
tion Research Initiative (CHMRI) [41], and the Dialogue
Model [36]. A summary of these frameworks is provided
in Table 2. Some priority setting exercises may develop
and use a different approach, and not necessarily follow
an existing or established framework.
Stakeholders or participants (items 12–16)
Stakeholder involvement in priority setting can vary
across the priority setting exercises. In some cases, they
are involved in all key stages of the process and in
others, they are consulted in specific steps and existing
data or documents are used instead of consultation.
Relevant stakeholders whose “values and interests should
Table 2 Summary of frameworks for conducting health research priority setting
Framework Year Organizationa Countrya Principles/values/
characteristics
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be respected in setting health research priorities” [41] can
include patients, caregivers, clinicians, policy makers,
representatives from non-governmental organizations [5,
18, 21, 39, 44]; and diverse groups, for example based on
demographic or clinical characteristics, may need to be
included in research priority setting [5, 18, 20, 36, 37, 39,
40, 42]. It has been emphasized that patients/caregivers
(and if relevant the public) need to be directly involved in
the priority setting process [5, 18, 38–40, 42], as they have
direct experience of the health condition or context and
often have different priorities to researchers and clinicians.
There is also recognition of the need to involve individuals
from vulnerable or marginalized groups, particularly in
equity-focused research priority setting exercises [5, 12,
21, 36, 39].
Multiple strategies may be used to engage stakeholders
in the priority setting process, and this is namely
through partnership with relevant stakeholder organiza-
tions [5, 39]. The number and characteristics of the
participants involved enables assessment of the degree of
inclusivity, diversity and equity [5, 13, 39] in priority
setting processes. The characteristics to specify may in-
clude role and expertise, discipline, organizational affilia-
tions, demographics (e.g. age, sex, socio-economics status,
ethnicity), and clinical factors [13, 21–23, 36, 42, 44]. Sup-
port for patients/caregivers involved in priority setting
may include reimbursement for travel, arranging care for
dependents, and time [5]. This may indicate to readers the
degree to which the team was able to ensure inclusivity
across the different groups. Of note, there is recognition
that attention must be given to power dynamics, otherwise
the engagement of disadvantaged and marginalized groups
may lead to “presence without voice and voice without in-
fluence.” [2] Therefore, it may be relevant to acknowledge
and discuss how hierarchies and “asymmetries between
stakeholders” [36] are addressed to maximize constructive
and balanced interaction. For example, some groups, such
as patients, may require additional time, training,
resources, or other strategies to be able to engage; to have
the opportunity to contribute meaningfully [36].
Identification and collection of research priorities (items 17–
22)
Different methods and approaches are available for col-
lecting and selecting initial research priorities from
stakeholders and developing the first list of priorities.
This can be one or a combination of methods including
interviews, focus groups, workshops, and surveys; and
consensus methods (e.g. Delphi survey, nominal group
technique); and these may be conducted through various
modes such as face-to-face or online [5, 13, 23, 25–28,
37–39]. Documents such as systematic reviews, technical
data, and other relevant reports may be used to identify
the initial list of priorities [5, 13, 18, 21, 24, 39, 40]. In
some priority setting exercises, the initial list of research
priorities is derived from literature or existing data ra-
ther than consultation or engagement of stakeholders
[47–49].
If a wide range of different initial research priorities
are submitted or identified, it can be challenging to
manage and synthesise to capture the diversity of views
in a concise manner, whilst also retaining the context
and nuances of the submissions. They may need to be
organized, usually by collating and categorizing them
into themes, topics or other relevant taxonomy [5, 22,
36, 38, 39, 41]; and by removing those that are “out-of-
scope,” [5] or duplicative [39]. They may then be trans-
lated into “indicative, researchable questions” [5] and
edited for clarity [21, 27, 35, 36, 38]. Some priority
setting exercises conduct cross checking of the priorities
against the evidence (i.e. systematic reviews [5]) and
evidence mapping [48, 50–52].
The number of research priorities identified at each
stage vary widely [24]. Generally, 10 to 20 questions/
topics are included in the final set of priorities [5, 23–26,
38, 40].
Prioritization of research topics/questions (items 23–24)
Prioritization techniques can include scoring, ranking,
voting, and ordering, and these are usually embedded in
similar methods and modes used for collecting priorities
as outlined in Section E. Some frameworks and priority
setting exercises use explicit criteria to prioritize ques-
tions [13, 21, 22, 38, 39]. Examples include condition-
related criteria (burden of disease, variation in care and
outcome, evidence gaps), and research-related criteria
(resources required, likelihood of success and impact)
[37, 42]. The CHNRI method proposes criteria includ-
ing: answerability, attractiveness (likely to be published
in high-impact journals), novelty, potential for transla-
tion, effectiveness (likely to identify better interventions),
affordability, deliverability, sustainability, public opinion
(acceptability to the general public), equity (leads to in-
terventions that will be accessible to marginalized or vul-
nerable populations), and cost and feasibility [27, 41].
Using specific criteria can facilitate a deliberative and ra-
tional process, particularly when there is limited infor-
mation [21]. It may be relevant to report the processes
for selecting, defining and changing the criteria. Of note,
the use of criteria can add complexity to the process,
and strategies may be needed to avoid inadvertent
exclusion of other stakeholder values that influence
prioritization. Whilst assigning scores based on such cri-
teria may be rational, there are concerns that it may give
a false sense of objectivity. The method for excluding
priorities at this stage i.e. based on a quantified thresh-
old or other criteria should be provided. Any processes
to appeal or challenge the results may be specified.
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Output (item 25)
The output should be “clear and of value to the research
community.” [5] The final priorities generated can range
from having a specific structure i.e. the Population,
Intervention, Comparator, Outcome (PICO) format [5,
37], to broader outputs such as topics or themes/areas
[38]. It is possible that components of PICO are not spe-
cified in original submission of priorities, or that it can-
not be applied to some types of research questions [5].
In some circumstances, attempting to produce very
technical research questions can potentially place non-
researchers, who may include community members, pa-
tients, caregivers, at a disadvantage, as they may feel un-
able to articulate or consider the specific technical
components. Also, consideration may need to be given
to ensure that the contextual data and values around the
questions are not missed. Some priority setting exercises
seek to identify broader themes or areas and translate
these into research questions after prioritization.
Evaluation and feedback (items 26–27)
While there is no “gold standard” [37] approach for
evaluating the process of research priority setting,
process evaluation can provide information about the ac-
ceptability, “reliability and usefulness” [37] of the process
and results [5, 13, 37]. Stakeholder satisfaction with the
process in terms of being able to engage and express
opinions, and whether the priorities are considered
meaningful and valid may be evaluated [13, 18]. Partici-
pants and stakeholders could have an opportunity to re-
view and provide feedback on the prioritized questions
[22, 36, 39]; and having “revision or appeal” [18] mecha-
nisms available to identify and address disagreements in
a constructive manner [18] have been suggested.
Implementation (items 28–29)
Strategies to implement the research priorities could in-
volve informing and garnering support from govern-
ment, policy makers, and funding agencies to allocate
funding and resources toward the priorities identified
[13, 19, 22, 39], and working with researchers to develop
proposals [5, 19, 39]. Assessing the impact of research
priority setting is challenging but needs to be considered
[5, 22]. This may include the impact on decision-
making, allocation of funding and resources, and re-
search output [18, 19, 38].
Funding and conflict of interest (items 30–31)
There are different sources of funding that can affect a
priority setting process. The funding and resources used
to conduct the priority setting exercise and support the
stakeholders (directly or indirectly) and whether the pri-
ority setting exercise is connected to a funding source to
support the identified research priorities. Reporting the
sources of funding and support is usually required. The
resources required for research priority setting will de-
pend on the size, scope, timeline, methods used, and
personnel required [5, 19], and providing information
about the budget may be useful for others who are plan-
ning on conducting research priority setting. It is recom-
mended that any relevant disclosures be stated for
transparency, to allow assessment of potential political
or commercial influences or undue bias [5, 13, 24]. For
example, pharmaceutical companies may have close ties
with patient organisations and clinicians, and the poten-
tial influence this may have on the priority setting
process would need to be addressed explicitly. This may
be declared at an individual level, or at a process or con-
textual level, for example, providing a narrative of any
political issues, conflict or controversies that may affect
the process, output or implementation of the priority
setting exercise [20].
Discussion
The REPRISE Guideline is intended to facilitate trans-
parent and comprehensive reporting of research priority
setting studies that involve stakeholders. The guideline
has 31 reporting items that cover 10 domains: context
and scope, governance and team, framework for priority
setting, stakeholders/participants, identification and col-
lection of research priorities, prioritization of research
topics, output, evaluation and feedback, translation and
implementation, and funding and conflict of interest.
The REPRISE guideline is flexible without being unduly
prescriptive because different approaches for health re-
search priority setting are necessary to ensure they are
contextually appropriate, respect the underpinning
values and criteria, and are feasible based upon resources
available. By piloting the guideline with a broad selection
of research priority setting studies, we have demon-
strated the feasibility, acceptability and relevance of the
REPRISE reporting guidelines. We emphasise that RE-
PRISE is not designed for making judgements about the
quality of the conduct in research priority setting
studies.
The REPRISE guideline may be used as a roadmap for
reporting research priority setting studies, or to assess
reporting of research priority setting studies as has been
done in systematic reviews [25, 26]. REPRISE is focussed
on the reporting of process or conduct and does not ad-
dress in detail the values and criteria for establishing
priorities, though these may be described in reporting
the process of prioritizing research topics/questions. We
did not conduct a Delphi survey, which has been used in
other reporting guidelines to prioritize and achieve
consensus on what reporting items should be included
[30, 31]. Instead, we sought to be comprehensive, in-
cluded all reporting items, and did not eliminate any
Tong et al. BMC Medical Research Methodology          (2019) 19:243 Page 8 of 11
items based on judgement about relevance or import-
ance. We believe this increases the practical utility of the
REPRISE checklist considering the diverse range of
methods and approaches that are used for research pri-
ority setting exercises unlike other reporting guidelines
which are based on study designs in one particular
domain.
We acknowledge that there may be other potentially
relevant items that could warrant further discussion,
consideration, and evidence to support their inclusion in
subsequent revisions of this framework. The items ad-
dressing diversity and hierarchies amongst group mem-
bers and the networks they represent, the criteria and
degree of formality in decision making processes, and
the medium of communication for sharing information
and making decisions are all factors affecting good group
decision making [53].. Additional factors, not addressed
by the priority setting literature, are the size of a group
making decisions, the time available for them to explore
their knowledge to make choices or solve problems and
the facilitation skills for managing constructive conflict.
We seek further feedback from researchers, end-users
and other stakeholders, to inform future efforts to refine
and revise the guideline as needed.
Conclusions
The REPRISE guideline has the potential to improve
transparency in reporting research priority setting stud-
ies. Improved explicitness in how research priority set-
ting studies are conducted could strengthen legitimacy,
confidence, and acceptability of the findings, and thereby
support the implementation and impact of these efforts.
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